Emerging Tests: Lab Industry Mobilizes to Develop Coronavirus Detection Test
...
Targeted Genetic Risk-Based Prostate Cancer Screening Would Save the Most Lives at the Best Costs: UK Study
...
FDA Watch: Agency Resounds the Alarm on Biotin Test Interference
In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The update reiterates the warning
Testing Trends: The Debate Continues Over Regular Colorectal Screening for Average Risk Adults
...
Nonculture Molecular Tests Speed Diagnosis of Bloodstream Infections
From - Diagnostic Testing & Emerging Technologies
The T2Bacteria Panel (T2Biosystems; Lexington, Mass.) can rapidly and accurately diagnoses bloodstream infections (BSIs) caused by…